Publications
2022
Metabolomics and biochemical alterations caused by pleiotrophin in the 6-hydroxydopamine mouse model of Parkinson’s disease.Gramage E, Sáiz J, Fernández-Calle R, Martín YB, Uribarri M, Ferrer-Alcón M, Barbas C, Herradón G.
Sci Rep. 2022 Mar 4;12(1):3577. doi: 10.1038/s41598-022-07419-6. PMID: 35246557; PMCID: PMC8897456.
2022
Pharmacogenetics of Donepezil and Memantine in Healthy SubjectsOvejero-Benito MC, Ochoa D, Enrique-Benedito T, Del Peso-Casado M, Zubiaur P, Navares M, Román M, Abad-Santos F
J Pers Med. 2022 May 13;12(5):788. doi: 10.3390/jpm12050788.
2021
Resolving the cellular specificity of TSPO imaging in a rat model of peripherally-induced neuroinflammationVicente-Rodríguez M, Singh N, Turkheimer F, Peris-Yague A, Randall K, Veronese M, Simmons C, Karim Haji-Dheere A, Bordoloi J, Sander K, Awais RO, Årstad E, Nima Consortium, Cash D, Parker CA.
Brain Behav Immun. 2021 Aug;96:154-167. doi: 10.1016/j.bbi.2021.05.025. Epub 2021 May 27.
2021
ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokineticsZubiaur P, Del Peso-Casado M, Ochoa D, Enrique-Benedito T, Mejía-Abril G, Navares M, Villapalos-García G, Román M, Abad-Santos F, Ovejero-Benito MC.
Biomed Pharmacother. 2021 Oct;142:112083. doi: 10.1016/j.biopha.2021.112083. Epub 2021 Aug 24.
2021
DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe PsoriasisSanz-Garcia A, Reolid A, Fisas LH, Muñoz-Aceituno E, Llamas-Velasco M, Sahuquillo-Torralba A, Botella-Estrada R, García-Martínez J, Navarro R, Daudén E, Abad-Santos F, Ovejero-Benito MC.
Acta Derm Venereol. 2021 May 4;101(5):adv00448. doi: 10.2340/00015555-3794.